Structure-guided allosteric modulation of the delta opioid receptor

Area of Science:

• Structural Biology
• Neuroscience
• Pharmacology

Background:

• Opioid analgesics are crucial for pain relief but cause adverse effects like respiratory depression, tolerance, and dependence.
• The delta-opioid receptor (δOR) is a potential target for safer analgesics compared to traditional mu-opioid receptor drugs.
• Positive allosteric modulators (PAMs) offer a way to enhance natural opioid signaling, potentially mitigating tolerance and dependence.

Purpose of the Study:

• To determine the high-resolution structure of the δOR in complex with a peptide agonist and a PAM.
• To elucidate the molecular mechanism of δOR allosteric modulation by a novel PAM.
• To provide a structural basis for designing improved, safer opioid therapeutics.

Main Methods:

• High-resolution cryo-electron microscopy (cryo-EM) to visualize the δOR-ligand complexes.
• Mutagenesis studies, molecular dynamics simulations, and structure-activity relationship (SAR) analyses.
• Structure-guided optimization to develop novel PAMs.

Main Results:

• Revealed a novel lipid-facing allosteric binding site for the PAM MIPS3614, involving transmembrane helices 2, 3, and 4.
• Demonstrated that MIPS3614 stabilizes the active δOR conformation via a hydrogen bond with residue N1313.35 in the sodium-binding site.
• Validated the allosteric modulation mechanism and developed an optimized compound, MIPS3983, with enhanced properties.

Conclusions:

• Established the first molecular framework for δOR allosteric modulation.
• Identified a critical interaction involving the sodium-binding site for GPCR activation.
• Provided a structural foundation for the rational design of safer δOR-targeting analgesics.